Lake Street analyst Frank Takkinen lowered the firm's price target on Inotiv to $3 from $5 and keeps a Buy rating on the shares. The firm, which thinks the "foundation is improving" and believes a refinancing, coupled with fewer headwinds, will allow shares to appreciate on "a realization of improved fundamentals," is lowering its target to account for its "conservatively revised estimates."
